Reneo Pharmaceuticals, Inc. (RPHM): Price and Financial Metrics

Reneo Pharmaceuticals, Inc. (RPHM): $1.82

0.09 (+5.20%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add RPHM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#78 of 333

in industry

RPHM Price/Volume Stats

Current price $1.82 52-week high $9.21
Prev. close $1.73 52-week low $0.98
Day low $1.68 Volume 437,500
Day high $1.90 Avg. volume 250,384
50-day MA $1.49 Dividend yield N/A
200-day MA $1.60 Market Cap 60.83M

RPHM Stock Price Chart Interactive Chart >


Reneo Pharmaceuticals, Inc. (RPHM) Company Bio


Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.


RPHM Latest News Stream


Event/Time News Detail
Loading, please wait...

RPHM Latest Social Stream


Loading social stream, please wait...

View Full RPHM Social Stream

RPHM Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!